Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00610181 · ClinicalTrials.gov registry record

Magnetic Resonance Imaging in Patients With Breast Cancer

A clinical trial of Breast Cancer, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
96
Enrollment target
1
Study location

NCT00610181: Completed study of Breast Cancer, sponsored by M.D. Anderson Cancer Center.

NCT00610181 is a study of Breast Cancer that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 96 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00610181, a study of Breast Cancer, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
96 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical research study is to learn how often magnetic resonance imaging (MRI) of the breast locates additional areas of cancer in the breast of patients with lobular cancer as well as in the breasts of young breast cancer patients (less than age 40 years). Researchers also hope to learn how often the results of the MRI changes the type of surgical treatment that is recommended and understand the costs associated with using MRI in the diagnostic process. Researchers also want to use a different way of looking at the MRI scans to learn if they can more easily learn the difference between a cyst and a tumor.

Conditions Studied

Interventions

  • PROCEDURE MRI

Study Locations (1)

Texas

  • University of Texas MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 96 participants
Start Date 2008-01

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT00610181

The ClinicalTrials.gov registry entry for NCT00610181 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (97% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which MRI is the first listed.

NCT00610181 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00610181 about?

NCT00610181 is a clinical study titled "Magnetic Resonance Imaging in Patients With Breast Cancer". The goal of this clinical research study is to learn how often magnetic resonance imaging (MRI) of the breast locates additional areas of cancer in the breast of patients with lobular cancer as well as in the breasts of young breast cancer patients (less than age 40 years). Researchers also hope to ...

What is the current status of trial NCT00610181?

This trial is currently completed. The enrollment target is 96 participants. The study started on 2008-01.

What conditions does trial NCT00610181 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT00610181?

The interventions under investigation include: MRI (PROCEDURE).

Who is sponsoring clinical trial NCT00610181?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00610181 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.